Get started
Author

Anna Maria Baldelli

Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
2002 · Stefano Cascinu, Vincenzo Catalano, et al. · Journal of Clinical Oncology · 421
Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.
2000 · S Cascinu, M P Staccioli, et al. · PubMed · 207
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
2009 · V Catalano, F Loupakis, et al. · British Journal of Cancer · 194
PDF
Thymidylate synthase (TS) protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil (5FU)
1999 · S. Cascinu, C. Aschele, et al. · European Journal of Cancer · 122
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
2011 · V. Catalano, F. Loupakis, et al. · Annals of Oncology · 108
PDF
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients
2002 · F Graziano, R Bisonni, et al. · British Journal of Cancer · 107
PDF
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
2008 · V Catalano, F Graziano, et al. · British Journal of Cancer · 101
PDF
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer
2000 · F. Graziano, V. Catalano, et al. · Annals of Oncology · 84
A systematic review of the role of pulmonary irradiation in the management of primary bone tumours
2002 · J.S. Whelan, R.J. Burcombe, et al. · Annals of Oncology · 82
PDF
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)
2002 · S. Cascinu, F. Graziano, et al. · Annals of Oncology · 52
PDF
Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: Relationships with tumor recurrence and resistance to adjuvant chemotherapy
2001 · S. Cascinu, F. Graziano, et al. · Annals of Oncology · 50
PDF
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer
2001 · S Cascinu, F Graziano, et al. · British Journal of Cancer · 47
PDF
A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases
2012 · Vincenzo Catalano, Renato Bisonni, et al. · Gastric Cancer · 45
PDF
An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation
2002 · S Cascinu, F Graziano, et al. · British Journal of Cancer · 45
PDF
Safety Profile and Activity of Lower Capecitabine Dose in Patients with Metastatic Breast Cancer
2007 · David Rossi, Paolo Alessandroni, et al. · Clinical Breast Cancer · 38
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
2006 · D Santini, F Graziano, et al. · BMC Cancer · 35
PDF
Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer
2008 · David Rossi, Anna Maria Baldelli, et al. · Anti-Cancer Drugs · 31
Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors
2000 · Stefano Cascinu, Francesco Graziano, et al. · Clinical & Experimental Metastasis · 29
HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer
2011 · Vincenzo Catalano, Pasquale Mellone, et al. · Histopathology · 26
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer
2001 · Francesco Graziano, Stefano Cascinu, et al. · BMC Cancer · 25
PDF
Weekly Paclitaxel in Elderly Patients (Aged ≥ 70 Years) with Advanced Non–Small-Cell Lung Cancer: An Alternative Choice? Results of a Phase II Study
2008 · David Rossi, Donatella Dennetta, et al. · Clinical Lung Cancer · 22
Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil—leucovorin combination
2000 · S. Cascinu, V. Catalano, et al. · Annals of Oncology · 22
PDF
Molecular markers predictive of response to chemotherapy in gastrointestinal tumors
2001 · Vincenzo Catalano, Anna Maria Baldelli, et al. · Critical Reviews in Oncology/Hematology · 20
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
2021 · M. E. Cazzaniga, I. Vallini, et al. · Breast Cancer Research and Treatment · 17
A Phase II Study of Single-Agent Oral Vinorelbine in Patients with Pretreated Advanced Non–Small-Cell Lung Cancer
2007 · David Rossi, Vincenzo Catalano, et al. · Clinical Lung Cancer · 16
Works count: 57
Citation count: 2,099
H-index: 22
I10-index: 31
Year
Topic
Type